In the US, Anakinra (anakinra systemic) is a member of the following drug classes: antirheumatics, interleukin inhibitors and is used to treat Cryopyrin-Associated Periodic Syndromes, Rheumatoid Arthritis, Schnitzler Syndrome and Still's Disease.
ATC (Anatomical Therapeutic Chemical Classification)
CAS registry number (Chemical Abstracts Service)
Disease-modifying antirheumatic drug, DMARD
Interleukin-1 receptor antagonist, IL-1Ra
Interleukin 1 receptor antagonist (human isoform x reduced), N2-L-metionyl (USAN)
N²-L-Metionylinterleukin 1 receptor antagonist (human isoform x reduced) (WHO)
- Anakinrum (Latin)
- Anakinra (German)
- Anakinra (French)
- Anakinra (Spanish)
- Anakinra (OS: USAN, BAN)
- Antril (Synergen) (IS)
- IRAP (IS)
- rhIL-1ra (IS)
A Menarini Australia, Australia; Amgen, Latvia; Amgen Europe, Netherlands; Biovitrum, Spain; Biovitrum, Greece; Biovitrum, Lithuania; Biovitrum AB, Cyprus; Biovitrum AB, Portugal; SOBI, Czech Republic; SOBI, Norway; SOBI, Sweden; Sobi - Swedish Orphan Biovitrum, Germany; Swedish Orphan, Belgium; Swedish Orphan, Iceland; Swedish Orphan, Italy; Swedish Orphan, Lithuania; Swedish Orphan, Poland; Swedish Orphan, Slovenia; Swedish Orphan Biovitrum, Canada; Swedish Orphan Biovitrum, Denmark; Swedish Orphan Biovitrum, Estonia; Swedish Orphan Biovitrum, Finland; Swedish Orphan Biovitrum, France; Swedish Orphan Biovitrum, United Kingdom; Swedish Orphan Biovitrum, Netherlands; Swedish Orphan Biovitrum, Romania; Swedish Orphan Biovitrum Ltd., Ireland
- Kineret [pediatric]
Sobi, Inc, United States
- Kineret 100mg
Swedish Orphan, Luxembourg; Swedish Orphan Biovitrum, Israel; Swedish Orphan International, Hungary
- Kineret 100mg/0,67ml
Swedish Orphan Biovitrum International, Austria
|BAN||British Approved Name|
|Rec.INN||Recommended International Nonproprietary Name (World Health Organization)|
|USAN||United States Adopted Name|
|WHO||World Health Organization|
Further information on drug naming conventions: International Nonproprietary Names.
Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.